News & Videos - COVETRUS INC. - English

Third quarter GAAP net sales of $1.13 billion, an increase of 11% year-over-year; non-GAAP organic net sales increased 12% year-over-year Third quarter GAAP net loss of $35 million; third quarter non-GAAP adjusted net income of $30 million, an increase of 58% year-over-year Third quarter non-GAAP adjusted EBITDA of $59 million, an increase of 20% year-over-year Ended the third quarter of 2020 with more than $650 million in available liquidity, including $355 million in cash and cash equivalents...

PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results after the market close on Tuesday, November 10 , 2020 . Following the release, the company will hold a conference call at 4:30 PM ET, during which Covetrus president and chief executive officer, Benjamin Wolin, and executive vice president and chief financial officer, Matthew Foulston, will review the...

Second quarter GAAP net sales of $1.03 billion, an increase of 2% year-over-year; non-GAAP organic net sales increased 5% year-over-year Second quarter GAAP net income of $54 million, including a $70 million after-tax gain on sale of scil animal care, as compared to a GAAP net loss of $10 million in the prior year period; second quarter non-GAAP adjusted net income of $30 million, an increase of 25% year-over-year Second quarter non-GAAP adjusted EBITDA of $63 million, an increase of 19%...

PORTLAND, Maine, July 28, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2020 results after the market close on Tuesday, August 11, 2020. Following the release, the company will hold a conference call at 4:30 PM EDT, during which Covetrus president and chief executive officer, Benjamin Wolin, and executive vice president and chief financial officer, Matthew Foulston, will review the...

PORTLAND, Maine, June 25, 2020 (GLOBE NEWSWIRE) -- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced today its board of directors has declared a quarterly cash dividend to holders of its 7.50% Series A Convertible Preferred Stock of $8.653846 per share payable on June 30, 2020 to holders of record on June 19, 2020. About Covetrus Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners...

First quarter GAAP net sales of $1.07 billion, an increase of 13% year-over-year; non-GAAP pro forma organic net sales increased 10% year-over-year First quarter GAAP net loss of $33 million as compared to a GAAP net loss of $13 million in the prior year period; first quarter non-GAAP adjusted net income of $20 million, an increase of 5% year-over-year on a pro forma basis First quarter non-GAAP adjusted EBITDA of $48 million, a decline of 4% year-over-year on a pro forma basis, and at the...

PORTLAND, Maine, May 05, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2020 financial results after the market close on Thursday, May 14, 2020 . The company will hold a conference call at 4:30 PM ET the same day. During the call, Ben Wolin, president and chief executive officer, and Stuart B. Gleichenhaus, interim chief financial officer, will review the financial results and provide...

PORTLAND, Maine, April 30, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today a $250 million investment from Clayton, Dubilier & Rice (CD&R), a leading private investment firm that has been a significant shareholder of the Company since its formation in 2019 and formerly of its predecessor company, Vets First Choice, since 2015. This additional capital significantly strengthens the Company’s financial profile and enables...

Operationally, all of the company's distribution centers and pharmacies currently remain open, as veterinary medicine has been deemed an essential service in most geographies around the globe Preliminary first quarter net sales of approximately $1.07 billion, an increase of 13% year-over-year; preliminary year-over-year non-GAAP pro forma organic net sales growth of 10% Preliminary first quarter loss before taxes and equity in earnings of affiliates in the range of $35 million to $36 million;...

Board of directors announces acting chief executive officer Benjamin Wolin to serve as president and CEO Fourth quarter net sales of $1.0 billion, an increase of 12% year-over-year; non-GAAP pro forma organic net sales increased 4% year-over-year Fourth quarter net loss of $37 million; non-GAAP adjusted net income of $20 million, a decline of 5% year-over-year on a pro forma basis Fourth quarter non-GAAP adjusted EBITDA of $47 million, a decline of 10% year-over-year on a pro forma basis Full...

PORTLAND, Maine, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release fourth quarter and full year 2019 results after the market close on Tuesday, March 3, 2020 . Following the release, the company will hold a conference call at 4:30 PM EDT , during which Covetrus acting president and chief executive officer, Benjamin Wolin, and interim chief financial officer, Stuart B. Gleichenhaus, will review...